Partnership

Homepage - Torlak Institute

Messenger Biopharma has established a partnership with the Torlak Institute for the development of an mRNA vaccine against the West Nile Virus.

Last news

business-model

Messenger Biopharma in the newspaper “La Montagne”

posted February 15, 2016

“Messenger Biopharma in the newspaper “La ...Read More